These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Use of therapeutic plasmapheresis in the exacerbation period of multiple sclerosis]. Neretin VIa; Kir'iakova VA; Sapfirova VA; Ivanov MI; Volkova EK Sov Med; 1988; (2):86-9. PubMed ID: 3388103 [No Abstract] [Full Text] [Related]
3. [Plasmapheresis in multiple sclerosis]. Fuchs S; Pogglitsch H; Ladurner G; Lechner H Wien Klin Wochenschr; 1984 Jan; 96(2):67-9. PubMed ID: 6710999 [TBL] [Abstract][Full Text] [Related]
4. [Plasmapheresis as a method of intensive care in neurology]. Piradov MA Anesteziol Reanimatol; 1996; (2):92-4. PubMed ID: 8754188 [No Abstract] [Full Text] [Related]
5. [The unresolved problems of plasmapheresis]. Vorob'ev AI; Gorodetskiĭ VM; Iakhnina EI Ter Arkh; 1994; 66(1):4-8. PubMed ID: 8146792 [No Abstract] [Full Text] [Related]
6. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
7. [Lymphocyto-plasmapheresis for relapsing multiple sclerosis]. Jyoichi T; Kamegai M; Noda Y; Shimojo S; Miyahara T Rinsho Shinkeigaku; 1986 Sep; 26(9):907-9. PubMed ID: 3791770 [No Abstract] [Full Text] [Related]
11. A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis. Ramunni A; De Robertis F; Brescia P; Saliani MT; Amoruso M; Prontera M; Dimonte E; Trojano M; Coratelli P Ther Apher Dial; 2008 Jun; 12(3):250-4. PubMed ID: 18503704 [TBL] [Abstract][Full Text] [Related]
12. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
13. Plasmapheresis in neurologic disorders. Dau PC Muscle Nerve; 1980; 3(6):529. PubMed ID: 6161306 [No Abstract] [Full Text] [Related]